Amyloid-beta binding proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9062101
APP PUB NO 20140227291A1
SERIAL NO

13988307

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to amyloid-beta (Aβ) binding proteins. Antibodies of the invention have high affinity to Aβ(20-42) globulomer or any Aβ form that comprises the globulomer epitope. Method of making and method of using the antibodies of the invention are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE DEUTSCHLAND GMBH & CO KG;ABBVIE INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barghorn, Stefan Mannheim, DE 33 596
Ebert, Ulrich Biberach, DE 33 642
Giaisi, Simone Edingen-Neckarhausen, DE 8 62
Hillen, Heinz Hassloch, DE 44 705
Hsieh, Chung-Ming Newton, US 120 1507
Striebinger, Andreas Speyer, DE 20 251

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 23, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00